University Medical Center Ljubljana

At University Medical Center Ljubljana, clinical research in Cardiovascular Diseases focuses on urgent bleeding management and improving care for patients who need surgery while taking anticoagulants. The studies are designed to evaluate whether new approaches can help control bleeding more effectively and support safer treatment decisions.

• Reversal of anticoagulation in patients taking factor Xa inhibitors
• Emergency surgery and procedure-related bleeding risk
• Testing a treatment approach to improve hemostasis and reduce bleeding complications

This work is especially relevant for people who require rapid, reliable bleeding control in high-risk surgical settings.

Research in Hemic and Lymphatic Diseases at the University Medical Center Ljubljana centers on Hemophilia A and Hemophilia B, with a strong focus on joint health and long-term disease management. The trials aim to better understand how prophylactic treatment may help preserve joint function and improve overall outcomes.

• Hemophilia A and B
• Joint status assessed with ultrasound
• Evaluating the effectiveness of preventive therapy for protecting joints

These studies support efforts to refine care for bleeding disorders and monitor how treatment may influence daily quality of life.